Andy Hsieh

+1 312 364 5051
Email vCard

Specialties:  Biotechnology

Andy Hsieh, Ph.D., a biotechnology analyst, joined William Blair in January 2014, after an internship as a research associate with Cowen & Company. Mr. Hsieh earned a Ph.D. in chemistry from the University of California, Berkeley and a B.S. in biological sciences from Carnegie Mellon University.

Viking Therapeutics, Inc.: Initiation of Research Coverage

William Blair & Company initiated research coverage of Viking Therapeutics, Inc. (VKTX $3.97). Viking is a clinical-stage biotechnology company developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Learn More